Anne Lally, MD
Transplant Surgery · Hartford, CTNPI 1891794087
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,257 of the $3,955 with a category attached, or 82.4%. Bard Peripheral Vascular, Inc. accounts for 62.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $1,425 and has fallen 88.8% since, to $160 in 2025.
Across 65 payments — averaging $60.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$2K
- Globus Medical$820
- Lemaitre Vascular, Inc.$171
- W. L. Gore & Associates, Inc.$164
- Laminate Medical Technologies Inc.$143
- Cook Medical LLC$112
- plus $77 from 4 others
What the payments were for
- Travel & lodging$69818%
- Food & beverage$3,25782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 42 | $2,468 |
| Globus Medical | 4 | $820 |
| Lemaitre Vascular, Inc. | 7 | $171 |
| W. L. Gore & Associates, Inc. | 3 | $164 |
| Laminate Medical Technologies Inc. | 1 | $143 |
| Cook Medical LLC | 4 | $112 |
| Inari Medical, Inc. | 1 | $20 |
| Angiodynamics, Inc. | 1 | $20 |
| Innocoll Pharmaceuticals Limited | 1 | $19 |
| Covidien LP | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 153 | $1,169 |
| ClopidogrelClopidogrel Bisulfate | 13 | $166 |
| Cephalexin | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Hartford
- Oscar SerranoHartford$6K
- Wasim DarHartford$6K
- Glyn MorganHartford$1K
- Patricia SheinerHartford$1K
- Sanjay KulkarniNew Haven$2K
- Gregory AziaNew London$387
- Joohyun KimNew Haven$227
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.